Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Creating Cash out of an Economy Crunch

(Image via Bombardier Inc.) If you’re looking to see the stocks that investors have been keeping an eye on over the past week, you’ve come to the right place. The Stockhouse community regularly acts as a microcosm of investor sen...

Gaming stocks that are worth tracking

Gaming has evolved from a pastime activity to become a career for some people and an educational tool for others. Gaming has produced some of the biggest global companies, such as Sony, Meta, Microsoft, and Tencent Holdings. How did companies like Microsoft and Meta get a...

Jackpot Digital (TSXV:JJ): Meet the company revolutionizing casino gaming

What does the future of casino gaming look like? Well, just imagine, for a moment, being on a cruise, playing the tables at the casino, and you hit a patch of rough waters. Well, Jackpot Digital, it seems, has thought of this. They signed a deal in 2017 with Carni...

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...

A Closer Look at Ximen's Kenville Gold Mine

Established in 1888, the Kenville Gold Mine was British Columbia's first underground operation. Historical records show 65,381 ounces gold produced from 158,842 tonnes milled, for a recovered grade of 12.8 grams per tonne (0.37 ounce per ton) gold. Drilling in the la...

Buzz on the Bullboards: Markets underperforming, or is the best yet to come?

So, the “September rally” didn’t really pan out as many indices hit lows not seen in months, but at least interest rates were kept firm for now, so that is some good news, right? Investors have been worried about the possibility o...

An emerging low in gold stocks?

Gold stocks have been in another recent downtrend, which makes sense during a “wave 2″ correction in gold. If we review the Market Vectors ETF Trust Market Vectors Gold Miners ( NYSE: GDX , Stock Forum ) we can see a possible triple bottom formation. This one though loo...
1 2 3 4 5 6 7 8 9 10 ...